Burton G. Malkiel, Director at Theravance Biopharma, Inc. (TBPH), bought 10,000 shares at $12.92 ($129K) on 2015-08-18, disclosed to the SEC on 2015-08-18.
Open-market purchase of $129k TBPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |